der(1)t(1;1)(p36;q10) as a Rare Variant of 1q Gain in Fanconi Anemia-Associated Myelodysplastic Syndrome

참고문헌 (9)

1. Cioc AM, "Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia: morphologic and cytogenetic characteristics", Am J Clin Pathol, 132, pp.92~100 (2010)
2. van de Vrugt HJ, "Effective CRISPR", Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair, 2019, pp.9, 768~
3. Quentin S, "Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1", AML1 lesions, 2011, pp.177, e161~e170
4. Kristin Karner, "Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis", Annals of Laboratory Medicine, 39(6), pp.509~514 (2019), 대한진단검사의학회[DOI]
5. Zamecnikova A, "der(1)t(1;1)(p36;q11-q32) in hematopoietic malignancies", Atlas Genet Cytogenet Oncol Haematol, 21, pp.150~155 (2017)
6. de Latour RP, "How I treat MDS and AML in Fanconi anemia", Blood, 127, pp.2971~2979 (2016)
7. Fu B, "Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems", Mod Pathol, 27, pp.681~689 (2014)
8. Della Porta MG, "Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes", Leukemia, 29, pp.66~75 (2015)
9. Duhoux FP, "PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies", Br J Haematol, 156, pp.76~88 (2012)

관련 논문AI추천